SAB Biotherapeutics has filed a notice of an exempt offering of securities to raise $175 Million in New Funding.
According to filings with the U.S. Securities and Exchange Commission, SAB Biotherapeutics is raising up to $175,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…